Sue
Analyst
LifeSci Capital
Equibles does not estimate personal net worth.
About Sue
Sue is recorded as Analyst at LifeSci Capital. Sue has spoken on 1 investor event across 1 company, most recently for Revolution Medicines, Inc. on May 31, 2026. The companies whose calls Sue spoke on are classified in the Healthcare sector.
Sue on recent calls
“Obviously, this is the first innovative drug in pancreatic cancer in a really long time.”
Affiliation history
-
LifeSci Capital
Analyst
Transcript header (unverified)
Current